Dear Reader,

When it comes to Elon Musk…

The question is always, “What will he think of next?”

Well, here’s a clue:

What if I told you Musk’s next project could be his biggest one yet?

According to tech visionary Ian King, that’s exactly what’s about to happen.

His research shows Elon Musk is working to completely 'reboot' the U.S. financial system.

But don’t expect to see the trillionaire’s face gracing the new $100 bill.

Instead, Musk is racing to replace "money as we know it" with an innovation that could make him the most powerful man on earth — and make his early backers a fortune.

This story is moving quickly, so go here to see all the details before Elon’s plan is fully rolled out.

Regards,

Ian King
Chief Strategist, Strategic Fortunes

Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?

Authored by Sam Quirke. Article Posted: 9/30/2026.

Shares of Netflix Inc. (NASDAQ: NFLX) have been stuck in a multimonth downtrend and, at $70, are trading close to where they were nearly two years ago. That kind of stagnation would test any investor's patience, especially with earnings less than three weeks away.

Yet one recent move by a major bank has caught investors' attention precisely because it seems to defy logic. Deutsche Bank earlier this week upgraded its rating on Netflix to Buy while simultaneously cutting its price target and lowering its earnings estimates.

The energy story near the Grand Canyon (Ad)

The largest energy source on Earth contains 50,000 times every oil and gas reserve on the planet combined - and much of it sits beneath the desert near the Grand Canyon.

A drilling crew just hit the DOE's 2035 targets twelve years early, with costs down 50% in 18 months. Google signed on, Gates invested, and the Pentagon made it a priority. One company has been quietly building this infrastructure for sixty years.

See the company sitting on the biggest energy source on Earth

At first glance, the move looks contradictory. But it actually reveals something important about how Wall Street separates near-term realities from longer-term opportunities. Deutsche Bank isn't saying Netflix's earnings outlook has improved. It's saying the stock has become cheap enough relative to the company's strategic position that the risk-reward has flipped decisively in investors' favor. Whether that thesis holds will depend on what is revealed in the earnings report in three weeks.

Inside the Reset in Expectations

While the firm raised its rating on the stock, Deutsche Bank analyst Bryan Kraft also reduced his price target from $100 to $95 and lowered his operating-income and free-cash-flow estimates.

The reductions acknowledge that the company's near-term growth trajectory may be less robust than the bank previously modeled, but the upgrade to Buy signals confidence that the stock's valuation has reset enough to compensate. In other words, lower earnings on a much lower multiple can still offer upside if the long-term opportunity remains intact.

Kraft's bullish thesis rests on several points. International engagement has grown year over year for the past four consecutive six-month periods, and more than 60% of Netflix's production now takes place outside the U.S., creating a content advantage that competitors struggle to replicate.

He also pointed to progress in Netflix's platform expansion and the ongoing rollout of AI in production, personalization, and advertising as reasons to be bullish. If this argument holds, even a stock with lowered estimates could still offer substantial upside if expectations have fallen even further.

Further Reasons to Be Bullish

The good news for the bulls is that Deutsche Bank isn't alone in finding the current risk-reward setup compelling. Evercore ISI recently raised its price target on Netflix to $110 while maintaining an Outperform rating. That represents targeted upside of more than 55%.

The team cited survey evidence of stronger U.S. and Japanese market penetration and lower churn intent, while also emphasizing live programming as a subscriber catalyst. Netflix becomes the exclusive Japanese home for WWE starting Oct. 1, and the historical record is worth noting: Six of Netflix's 10 strongest new-member sign-up days over the past five years occurred when major live events were available.

Management's third-quarter guidance also supports this broader monetization narrative. Netflix has said revenue growth should come from membership increases, pricing, and higher advertising revenue, with improvements to its ad technology stack, demand sources, measurement, and fill rates all representing potential monetization opportunities.

If advertising can grow faster than traditional revenue, or if the company can layer incremental ad revenue on top of a maturing subscriber base, even modest subscriber growth could drive meaningful earnings leverage.

Why the Bears Disagree

That said, not every major analyst sees a bargain. HSBC downgraded Netflix this month from Buy to Hold and cut its price target to $76, arguing that YouTube represents too much of a competitive threat to viewer time and creator economics.

The bear case points to weaker reception for Netflix originals, streaming fatigue across the sector, and potential pressure on retention, pricing power, and advertiser appeal. HSBC's take is straightforward: Revenue is decelerating, advertising remains a relatively small contributor, and the company may be approaching maturity faster than new monetization initiatives can compensate.

Wells Fargo also joined the bearish camp this month, cutting its rating on the stock to Underweight and lowering its price target all the way to $57. That implies a decline of about 18% from where Netflix shares are currently trading—enough to make even the most faithful bull a little nervous heading into next month's report.

The Earnings Inflection Point

With earnings due in around three weeks, the market will increasingly focus on advertising revenue growth, membership and pricing trends, and evidence that international engagement is translating into actual revenue and retention. The central question is whether Netflix is moving from a subscriber-led growth model to a broader monetization machine, or whether it's slowing down faster than these new initiatives can offset.

Deutsche Bank's contradictory-sounding update resolves itself once you separate the two questions. The upgrade isn't a bet that Netflix's near-term earnings are improving—they're not. It's a bet that the valuation has reset enough that the longer-term opportunity no longer requires perfection to work out. For a stock that's been treading water for two years, that distinction could matter more than the price target cut.

Why Concentra’s Quiet Healthcare Business Keeps Winning

Authored by Peter Frank. Article Posted: 10/2/2026.

Most investors have never been to a Concentra (NYSE: CON) clinic, and that’s good news.

The Texas-based company treats workers injured on the job and conducts the drug tests, physicals and pre-employment screenings that employers need.

The $100 Stock Behind Elon's Next Move (Ad)

A small, publicly traded supplier trading under $100 a share has reportedly worked alongside Elon Musk for more than a decade.

A federal filing may outline Musk's next major move: an AI network of up to a million satellites powered by the sun. James Altucher says this supplier holds the piece Musk doesn't own.

Watch James Altucher's free Masterclass on this Musk-linked supplier stock

It’s not glamorous, but Concentra is the largest occupational health provider in the country, and business has rarely looked better.

Since Select Medical spun it off in 2024, Concentra has become one of the better healthcare stories on Wall Street.

The company is growing, widening its margins, paying down debt and paying a dividend all at the same time. Wall Street sees more upside ahead and has given the stock a unanimous Buy rating.

The harder question is price. After a big run in the stock, investors weighing Concentra need to decide whether a steady, blue-collar healthcare business can continue to justify a much richer price tag.

Earnings Show Concentra’s Strength

The numbers show how Concentra is pulling ahead. The company’s second-quarter report on Aug. 6 beat expectations across the board. Revenue rose 10% to $606 million, above analysts’ projections of $592 million. Adjusted earnings per share came in at 52 cents, well ahead of the 42 cents analysts expected.

The growth came from two simple levers: more patients and higher prices. Both daily patient visits and revenue per visit rose, while workers’ compensation visits, the heart of the business, grew as well.

Profits increased even faster than sales. Net income attributable to the company came in at $65.3 million, up 46.5% from a year earlier, and margins widened.

Cash flow is the real engine. Free cash flow nearly doubled in the quarter, and using it to pay down debt should lower the company’s borrowing costs. Management raised its full-year outlook again and now expects 2026 revenue of $2.325 billion to $2.375 billion.

Growth Extends Across the Business

The positive side of the story is simple. Concentra dominates a fragmented market and is using its size to buy smaller rivals and open new centers.

Revenue grew at a double-digit pace last year, and the company has met or beaten its guidance in every quarter since its July 2024 IPO.

It is also returning cash to shareholders through a quarterly dividend of 25 cents. In August, it bought back 1 million shares from the company’s outgoing chairman, Robert A. Ortenzio, and related entities.

Growth initiatives continue as well. With 633 occupational health centers and 415 onsite health centers, Concentra recently bought four more occupational health centers in Minnesota’s Twin Cities and opened new centers in Boise, Kansas City and Daytona Beach.

Credit markets have noticed. S&P Global upgraded Concentra’s credit rating on Aug. 27, citing strong performance and lower leverage.

Wall Street Sees More Upside

Wall Street firmly supports the company’s direction. All eight analysts covering the stock rate it a Buy, with one assigning a Strong Buy.

With the stock already up roughly 75% this year, the 12-month consensus price target is $39.40, meaning analysts expect it to rise another 14% or so. The highest price target is currently $43 per share, while the lowest is $30.

Labor Market Could Weigh on Growth

Although business is strong, there are risks. The most important is that Concentra’s fortunes are tied to the blue-collar job market. Fewer workers on factory floors, in warehouses and on construction sites would mean fewer injuries to treat and fewer new hires to screen.

Management has credited a resilient labor market for strong visit growth, but that tailwind could fade quickly if the economy cools. Pricing growth is also expected to slow for the rest of the year.

Debt and Competition Add Risks

There are other reasons for caution as well. Concentra still carries a sizable debt load of $1.57 billion, and much of its pricing is set by state workers’ compensation fee schedules that it does not control. The company faces competition from hospital systems, urgent care chains and physical therapy providers, such as U.S. Physical Therapy (NYSE: USPH).

Concentra is also in the middle of a leadership transition. On Nov. 1, President and CFO Matt DiCanio will become CEO, while longtime chief executive Keith Newton will move to executive chairman. Robert Ortenzio will step down as chairman but remain on the board. On Sept. 8, Concentra named Tanner Newton, its senior vice president of strategy and finance, as the next CFO.

Strong Execution Faces a Valuation Test

Concentra is executing well. The business is growing, margins are widening, debt is coming down and the management transition is orderly, with successors promoted from within. Wall Street sees more upside ahead.

But a new CEO and CFO taking over at the same time adds some execution risk. Investors also need to keep in mind that much of the good news is reflected in a stock that has run sharply higher this year.

The next test comes with third-quarter results, expected in early November, just as the new leadership team takes over.